The natural history of pediatric ulcerative colitis: A population-based cohort study

American Journal of Gastroenterology

Volumn 104, Issue 8, 2009, Pages 2080-2088

  Gower Rousseau, Corinne ^a   Dauchet, Luc ^a   Vernier Massouille, Gwénola ^a   Tilloy, Emmanuelle ^a   Brazier, Franck ^b   Merle, Véronique ^c   Dupas, Jean Louis ^b   Savoye, Guillaume ^c   Baldé, Mamadou ^a   Marti, Raymond ^a   Lerebours, Ric ^c   Cortot, Antoine ^a   Salomez, Jean Louis ^a   Turck, Dominique ^a   Colombel, Jean Frédéric ^d  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b AMIENS UNIVERSITY HOSPITAL   (France)

^c EPIMAD   (France)

^d UNIV LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; ENEMA; METHOTREXATE;

ADOLESCENT; ARTICLE; ARTIFICIAL FEEDING; CHILD; COLON RESECTION; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; POPULATION RESEARCH; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; ULCERATIVE COLITIS;

EID: 68349157711     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2009.177     Document Type: Article

References (48)

1. Cosgrove M, Al-Atia RF, Jenkins HR. The epidemiology of paediatric inflammatory bowel disease. Arch Dis Child 1996;74:460-1.
2. Sawczenko A, Sandhu BK, Logan RF et al. Prospective survey of childhood inflammatory bowel disease in the British Isles. Lancet 2001;357:1093-4.
3. Lindberg E, Lindquist B, Holmquist L et al. Inflammatory bowel disease in children and adolescents in Sweden, 1984-1995. J Paediatr Gastroenterol Nutr 2000;30:259-64.
4. Auvin S, Molinie F, Gower-Rousseau C et al. Incidence, clinical presentation and localisation at diagnosis of paediatric inflammatory bowel disease: a prospective population-based study in northern France (1988-1999). J Paediatr Gastroenterol Nutr 2005;41:49-55.
5. Tourtelier Y, Dabadie A, Tron I et al. Incidence of inflammatory bowel disease in children in Brittany (1994-1997). Breton association of study and research on digestive system diseases (Abermad). Arch Paediatr 2000;7:377-84.
6. Hassan K, Cowan FJ, Jenkins HR. The incidence of childhood inflammatory bowel disease in Wales. Eur J Paediatr 2000;159:261-3.
7. Barton JR, Gillon S, Ferguson A. Incidence of inflammatory bowel disease in Scottish children between 1968 and 1983; marginal fall in ulcerative colitis, three-fold rise in Crohn's disease. Gut 1989;30:618-22.
8. Olafsdottir EJ, Fluge G, Haug K. Chronic inflammatory bowel disease in children in western Norway. J Paediatr Gastroenterol Nutr 1989;8:454-8.
9. Langholz E, Munkholm P, Krasilnikoff PA et al. Inflammatory bowel diseases with onset in childhood. Clinical features, morbidity, and mortality in a regional cohort. Scand J Gastroenterol 1997;32:139-47.
10. Pozler O, Maly J, Bonova O et al. Incidence of Crohn disease in the Czech Republic in the years 1990 to 2001 and assessment of paediatric population with inflammatory bowel disease. J Paediatr Gastroenterol Nutr 2006;42:186-9.
11. Armitage EL, Aldhous MC, Anderson N et al. Incidence of juvenile-onset Crohn's disease in Scotland: association with northern latitude and affluence. Gastroenterology 2004;127:1051-7.
12. van der Zaag-Loonen HJ, Casparie M, Taminiau JA et al. The incidence of paediatric inflammatory bowel disease in the Netherlands: 1999-2001. J Paediatr Gastroenterol Nutr 2004;38:302-7.
13. Vind I, Riis L, Jess T et al. Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003-2005: a population-based study from the Danish Crohn colitis database. Am J Gastroenterol 2006;101:1274-82.
14. Faubion WA Jr, Loft us EV Jr, Harmsen WS et al. The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. Gastroenterology 2001;121:255-60.
15. Gower-Rousseau C, Salomez JL, Dupas JL et al. Incidence of inflammatory bowel disease in northern France (1988-1990). Gut 1994;35:1433-8.
16. Molinie F, Gower-Rousseau C, Yzet T et al. Opposite evolution in incidence of Crohn's disease and ulcerative colitis in Northern France (1988-1999). Gut 2004;53:843-8.
17. Silverberg MS, Satsangi J, Ahmad T et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005; 19 (Suppl A): 5-36.
18. Henriksen M, Jahnsen J, Lygren I et al. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study. Gut 2008;57:1518-23.
19. Hyams JS, Davis P, Grancher K et al. Clinical outcome of ulcerative colitis in children. J Paediatr 1996;129:81-8.
20. Barton JR, Ferguson A. Clinical features, morbidity and mortality of Scottish children with inflammatory bowel disease. Q J Med 1990;75:423-39.
21. Van Limbergen J, Russell RK, Drummond HE et al. Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease. Gastroenterology 2008;135:1114-22.
22. Kugathasan S, Judd RH, Hoffmann RG et al. Epidemiologic and clinical characteristics of children with newly diagnosed inflammatory bowel disease in Wisconsin: a statewide population-based study. J Paediatr 2003;143:525-31.
23. Mendeloff AI, Calkins B. The epidemiology of inflammatory bowel disease. In Kirsner JB, Shorter RG (eds). Inflammatory Bowel Disease. Lea and Febiger: Philadelphia, 1988, pp 3-34.
24. Russel RK, Satsangi J. IBD: a family affair. Best Pract Res Clin Gastroenterol 2004;18:525-39.
25. Laharie D, Debeugny S, Peeters M et al. Inflammatory bowel disease in spouses and their offspring. Gastroenterology 2001;120:816-9.
26. Biancone L, Michetti P, Travis S et al. European evidence-based Consensus on the management of ulcerative colitis: special situations. J Crohn's Colitis 2008;2:63-92.
27. Monsen U, Brostr ö m O, Nordenvall B et al. Prevalence of inflammatory bowel disease among relatives of patients with ulcerative colitis. Scand J Gastroenterol 1987;22:214-8.
28. Ahmad T, Tamboli CP, Jewell D et al. Clinical relevance of advances in genetics and pharmacogenetics of IBD. Gastroenterology 2004;126:1533-49.
29. Satsangi J, Welsh KI, Bunce M et al. Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease. Lancet 1996;347:212-7.
30. Carter MJ, di Giovine FS, Jones S et al. Association of the interleukin 1 receptor antagonist gene with ulcerative colitis in Northern European Caucasians. Gut 2001;48:461-7.
31. Pierik M, Joossens S, Van Steen K et al. Toll-like receptor-1, -2, and -6 polymorphisms influence disease extension in inflammatory bowel diseases. Inflamm Bowel Dis 2006;12:1-8.
32. Michener WM, Farmer RG, Mortimer EA. Long-term prognosis of ulcerative colitis with onset in childhood or adolescence. J Clin Gastroenterol 1979;1:301-5.
33. Ferry GD, Kirschner BS, Grand RJ et al. Olsalazine versus sulfasalazine in mild to moderate childhood ulcerative colitis: results of the Paediatric Gastroenterology Collaborative Research Group Clinical Trial. J Paediatr Gastroenterol Nutr 1993;17:32-8.
34. Baumgart DC, Sandborn WJ. Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet 2007;369:1641-57.
35. Hyams J, Markowitz J, Lerer T et al. The natural history of corticosteroid therapy for ulcerative colitis in children. Clin Gastroenterol Hepatol 2006;4:1118-23.
36. Kader HA, Mascarenhas MR, Piccoli DA et al. Experiences with 6-mercaptopurine and azathioprine therapy in paediatric patients with severe ulcerative colitis. J Paediatr Gastroenterol Nutr 1999;28:54-8.
37. Fuentes D, Torrente F, Keady S et al. High-dose azathioprine in children with inflammatory bowel disease. Aliment Pharmacol Ther 2003;17:913-21.
38. Vernier-Massouille G, Balde M, Salleron J et al. Natural history of paediatric Crohn's disease: a population-based cohort study. Gastroenterology 2008;135:1106-13.
39. Lichtiger S, Present DH, Kornbluth A et al. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 1994;330:1841-5.
40. Farmer RG, Easley KA, Rankin GB. Clinical patterns, natural history, and progression of ulcerative colitis. A long-term follow-up of 1116 patients. Dig Dis Sci 1993;38:1137-46.
41. Lakatos L, Pandur T, David G et al. Association of extra-intestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: results of a 25-year follow-up study. World J Gastroenterol 2003;9:2300-7.
42. Henriksen M, Jahnsen J, Lygren I et al. Ulcerative colitis and clinical course: results of a 5-year population-based follow-up study (the IBSEN study). Inflamm Bowel Dis 2006;12:543-50.
43. Hoie O, Wolters FL, Riis L et al. Low colectomy rates in ulcerative colitis in an unselected European cohort followed for 10 years. Gastroenterology 2007;132:507-15.
44. Howarth LJ, Wiskin AE, Griffiths DM et al. Outcome of childhood ulcerative colitis at 2 years. Acta Paediatrica 2007;96:1790-3.
45. Greenstein AJ, Janowitz HD, Sachar DB. The extra-intestinal complications of Crohn's disease and ulceraitive colitis: a study of 700 patients. Medicine 1976;55:401-12.
46. Orchard TR. Arthritis associated with inflammatory bowel disease. In Bayless TM, Hanauer SB (eds). Advanced Therapy of Inflammatory Bowel Disease. Decker Inc.: Hamilton, 2001, pp. 279-82.
47. Orchard TR, Chua CN, Ahmad T et al. Uveitis and erythema nodosum in inflammatory bowel disease: clinical features and the role of HLA genes. Gastroenterology 2002;123:714-8.
48. Roussomoustakaki M, Satsangi J, Welsh K et al. Genetic markers may predict disease behavior in patients with ulcerative colitis. Gastroenterology 1997;112:1845-53.